Remove Contamination Remove Pharma Companies Remove Reagent
article thumbnail

Top 10 Biotech Trends for 2025

XTalks

Biomanufacturing and Automation The production of vaccines, drugs and diagnostic reagents increasingly depends on good manufacturing practice (GMP) facilities for the manufacturing of critical reagents, a reliance that has intensified since the pandemic. percent from 2021 to 2031, reaching an estimated value of $85.2 billion by 2031.

article thumbnail

How Can Rapid mRNA Quantification Enhance Multivalent Vaccine Development?

XTalks

While RT-PCR methods can handle some level of multiplexing, they do require specialized, contamination-free environments. Rapid assays that can deliver same-day results are highly attractive to pharma companies, as they eliminate lengthy sample queues often seen with centralized or outsourced testing.

Vaccine 64